Preoperative Radiotherapy Combined with Capecitabine Chemotherapy in Chinese Patients with Locally Advanced Rectal Cancer

Journal of Gastrointestinal Surgery

Volumn 15, Issue 10, 2011, Pages 1858-1865

  Jin, Jianhua ^a   Meng, Hua ^b   Zhou, Guanghua ^c   Xu, Xuezhong ^a   Xue, Zhixin ^a   Xu, Xiyuan ^d   Wang, Fang ^a   Lu, Wenbin ^a   Li, Xianwen ^a   Zhang, Hua ^a   Deng, Jianzhong ^a  

^a Wujin Hospital Affiliated with Jiangsu University   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Department of Oncology   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Capecitabine; Chemoradiotherapy; Locally advanced rectal cancer

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CHINA; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RECTUM TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; CHINA; COHORT STUDIES; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053120939     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1637-0     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004; 40: 219-224.
3. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
4. Rouanet P, Rivoire M, Lelong B, Rullier E, Dravet F, Mineur L, et al.: Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: GRECCAR 1. 2006 ASCO Annual Meeting Proceedings. J Clin Oncol 24: 18S, 2006 (abstr 3527).
5. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.
6. Wagner TD, Fakih MG, Yang GY. Management of stage II/III rectal cancer. J Gastrointest Oncol 2010; 1: 112-119.
7. Vonk DT, Hazard LJ. Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. J Gastrointest Oncol 2010; 1: 45-54.
8. Schüller J, Cassidy J, Dumont E, Roos B, Durston S, Banken L, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45: 291-297.
9. Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y, Ishitsuka H. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 1999; 5: 2948-2953.
10. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2. 0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 13-47.
11. Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C, et al. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 1999; 17: 485-493.
12. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum 1997; 40: 131-139.
13. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 21; 351: 1731-1740.
14. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002; 54: 403-408.
15. Kocakova I, Spelda S, Svoboda M, Vyzula R, Kocak I, Brancikova D, et al. Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy [Abstract]. Proc Am Soc Clin Oncol 2003; 22: 322.
16. Dunst J, Reese T, Debus J, Hoelscher W, Budach V, Rudat J, et al. Phase II study of preoperative chemoradiation with capecitabine in rectal cancer [Abstract]. Proc Am Soc Clin Oncol 2004; 23: 260.
17. Wong SJ, Sadasiwan C, Erickson B, Ota D, Mulkerin D, Thomas J, et al. A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer [Abstract]. Proc Am Soc Clin Oncol 2004; 23: 312.
18. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta G, Delprete S, et al. A phase II study of capecitabine (CAP) and pre-operative radiation therapy (RT) in resectable, locally advanced rectal cancer (LARC) [Abstract]. Proc Am Soc Clin Oncol 2004; 23: 255.
19. Dupuis O, Vie B, Lledo G, Hennequin C, Noirclerc M, Bennamoun M, et al. Capecitabine (X) chemoradiation (CRT) in the perioperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial [Abstract]. Proc Am Soc Clin Oncol 2004; 23: 255.
20. Chen YJ, Chung V. Challenges toward personalized treatment of localized colorectal cancer. J Gastrointest Oncol 2010; 1: 74-75.
21. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, et al. Preoperative concurrent radiotherapy with capcitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol phys 2005; 63: 346-353.
22. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al. Capcitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006; 17: 246-251.
23. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, et al. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66: 762-771.
24. Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 2007; 97: 1333-1337.
25. Velenik K, Anderluh F, Oblak I, Strojan P, Zakotnik B. Capcitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: Prospective phase II trial. Croat Med J 2006; 47: 693-700.
26. Elwanis MA, Maximous DW, Elsayed MI, Mikhail NN. Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial. World J Surg Oncol 2009; 7: 52.
27. De Bruin AF, Nuyttens JJ, Ferenschild FT, Planting AS, Verhoef C, De Wilt JH. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med 2008; 66: 71-76.
28. Dunst J, Debuse J, Rudat V, Wulf J, Budach W, Hoelscher T, et al. Neoadjuvant capcitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: Mature results of a phase II trial. Strahlenther Onkol 2008; 184: 450-456.
29. Dupuis O, Vie B, Liedo G, Hennequin C, Noirclerc M, Bennamoun M, Jacob JH. Preoperative treatment combining cabcitabine with radiation therapy in rectal cancer: A GERCOR phase II study. Oncology 2007; 73: 169-176.
30. Korkolis DP, Boskos CS, Plataniotis GD, Gontikakis E, Karaitianos IJ, Avgerinos K, et al. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res 2007; 27: 541-545.
31. Cancer and Leukemia Group B 89901, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006; 24: 2557-2562.
32. Sastre J, Custodio A, Sanchez JC, Ortega L, Rodriguez L, Puente J, et al. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N + rectal cancer. Anticancer Drugs 2011; 22: 185-190.
33. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; on behalf of the Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer: Preliminary Results of a Multicenter, Nonrandomized Phase II Prospective Trial. Ann Surg 2011; 254: 97-102.
34. Dipetrillo T, Pricolo V, Lagares-Garcia J, Vrees M, Klipfel A, Cataldo T, et al. Neoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal Cancer. Int J Radiat Oncol Biol Phys 2010 Oct 13. doi: 10. 1016/j. ijrobp. 2010. 08. 005.
35. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994; 30: 169-175.
36. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-1038.
37. Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836.
38. Liu G, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997; 15: 110-115.
39. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396.